Sep 09, 2021 / 07:30PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
Great. Good afternoon, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here. Very pleased to have Will Lewis, the CEO of Insmed with us.
Quickly before we get started, I just need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.
Questions and Answers:
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive DirectorSo Will, thanks for being here. I thought maybe we'd start off with TPIP, just because you've got some upcoming data there. And maybe the best place to start is just talk to people because I think they're probably a little less familiar, I know you've probably been educating people here, but less familiar with the kind of study you're running here and the endpoints. And so maybe just help people think
Trustpilot
